-
The continuing global emergence of multidrug resistant gram negative pathogens bugs that are virtually impervious to all antibiotics and can transfer resistance mechanisms between species means infection prevention is more critical than ever during every patient encounter.
-
Threatening to spread to North America after originating in hospitals in India, the pan-resistant New Delhi metallo-beta-lactamase (NDM-1) enzyme has been linked to a fatal infection in Canada.
-
In a lingering legacy of the H1N1 pandemic, stronger protections are now advised for seasonal influenza than was the case prior to the emergence of the novel H1N1 strain. That distinctive status was recently highlighted in new influenza guidance in California.
-
Central line-associated infections, particularly bloodstream infections (BSI), remain a huge issue in our technological age. Four academic medical centers were used to accumulate 165,963 central-line days associated with 241,518 patient days.
-
The public is getting savvier by the day regarding what is expected in healthcare facilities from an infection prevention standpoint. It wasn't too long ago that communication with the general public was an uncommon occurrence.
-
Infection preventionists appear to be on the rebound with the national economy, gradually regaining program resources and improved compensation as healthcare associated infections (HAIs) continue to draw unprecedented public attention and regulatory activity.
-
-
Close on the heels of the first positive findings reported in microbicides and vaccine research ventures, the iPrEx study has shown that a pre-exposure prophylaxis (PrEP) combination drug demonstrates 44% additional protection from HIV infection.
-
Opt-out HIV testing goals by the Centers for Disease Control and Prevention (CDC) of Atlanta, GA, would have greater success if states were to reduce legislative barriers, an expert says.
-
[Editor's note: With the recent news that the U.S. Food and Drug Administration (FDA) has approved a new HIV test that obtains results within one minute, domestic HIV testing and prevention strategies have a new tool to employ. AIDS Alert asked Philip Bligh, president of bioLytical Laboratories in Vancouver, British Columbia and Chicago, IL, to answer questions in writing about his company's INSTI test. His responses are shown in this Q&A story]:
